Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Hepatitis viruses in Ethiopia: a systematic review and meta-analysis

Authors: Yeshambel Belyhun, Melanie Maier, Andargachew Mulu, Ermias Diro, Uwe Gerd Liebert

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia.

Methods

A comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science.

Results

The overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia.

Conclusions

This review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention.
Appendix
Available only for authorised users
Literature
1.
WHO. Global policy report on the prevention and control of viral hepatitis. WC: WHO member states; 2013. p. 536.
2.
Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci. 2011;4:7–13.CrossRef
3.
Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–7.CrossRefPubMed
4.
Kim J, Nelson KE, Panzner U, et al. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis. 2014;14:308.
5.
Alves C, Branco C, Cunha C. Hepatitis Delta Virus: A Peculiar Virus. Adv Virol. 2013;2013(3):1–11.
6.
Tsega E. Current views on liver diseases in Ethiopia. Ethiop Med J. 1977;15(2):75–82.PubMed
7.
Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. IJIAS. 2014;9(4):1718–23.
8.
Dessie A, Abera B, Wale F. Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, Northwest Ethiopia. EJHD. 2007;21(1):68–9.
9.
Diro E, Alemu S. G/Yohannes A. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital. Ethiop Med J. 2008;46(1):7–13.PubMed
10.
Mazengia A, Yismaw G, Anagaw B, Unakal C. Seroprevalence and associated risk factors of HBV and HCV among people attending the HIV VCT centre at Deber Markos Referral Hospital, Northwest Ethiopia. J Pharm Biomed Sci. 2013;30:22.
11.
Alemayehu A, Tassachew Y, Sisay Z, et al. Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia. BMC Res Notes. 2011;4:193.CrossRefPubMedPubMedCentral
12.
Hadush H, Gebre-Selassie S, Mihret A. Hepatitis C virus and human immunodeficiency virus coinfection among attendants of voluntary counseling and testing centre and HIV follow up clinics in Mekelle Hospital. Pan Afr Med J. 2013;14:107.CrossRefPubMedPubMedCentral
13.
Assefa A, Mathewos B, Alemu A, et al. Hepatitis B and C viral infections among blood donors at Bahir Dar, Ethiopia. IJMRHS. 2013;2(3):624–30.
14.
Huruy K, Kassu A, Mulu A, et al. Seroprevalence and Risk Factors for Hepatitis B Virus Infection in the Healthy Blood Donors at Jimma University Hospital, Southwest Ethiopia. Pharmacologyonline. 2008;3:32–7.
15.
Yami A, Alemseged F, Hassen A. Hepatitis B and C Viruses Infections and Their Association with Human Immunodeficiency Virus: A Cross-Sectional Study among Blood Donors in Ethiopia. Ethiop J Health Sci. 2011;21(1):67–75.CrossRefPubMedPubMedCentral
16.
Rahlenbeck SI, Yohannes G, Molla K, et al. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. Int J STD AIDS. 1997;8(4):261–4.CrossRefPubMed
17.
Tessema B, Yismaw G, Kassu A, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10:111.CrossRefPubMedPubMedCentral
18.
Harvard Initiative for Global Health, Institute for Health metrics and evaluation at the University of Washington, Johns Hopkins University, University of Queensland, World Health Organization. The global burden of diseases, injuries, and risk factors study operations manual final draft. 2008.
19.
Moher D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009;151(4):264.CrossRefPubMed
20.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomized studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.CrossRefPubMedPubMedCentral
21.
22.
Higgins P T J. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–60.CrossRef
23.
24.
Frame JD. Hepatitis among missionaries in Ethiopia and Sudan. Susceptible at high risk. JAMA. 1968;203(10):819–26.CrossRefPubMed
25.
Kefene H, Rapicetta M, Rossi GB, et al. Ethiopian National Hepatitis B Study. J Med Virol. 1988;24(1):75–84.CrossRefPubMed
26.
Rapicetta M, Hailù K, Morace G, et al. Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia. Eur J Epidemiol. 1989;5(4):481–5.CrossRefPubMed
27.
Abebe A, Nokes DJ, Dejene A, et al. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect. 2003;131(1):757–70.CrossRefPubMedPubMedCentral
28.
Berhe N, Myrvang B, Gundersen SG. Intensity of Schistosoma mansoni, hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): a large-scale community-based study in Ethiopia. Am J Trop Med Hyg. 2007;77(6):1079–86.PubMed
29.
Kefenie H, Desta B, Abebe A, et al. Prevalence of hepatitis B infection among hospital personnel in Addis Ababa (Ethiopia). Eur J Epidemiol. 1989;5(4):462–7.CrossRefPubMed
30.
Geberemicheal A, Gelaw G, Moges F, Dagnew M. Seroprevalence of hepatitis B virus infections among health care workers at the Bulle Hora Woreda Governmental Health Institutions, Southern Oromia, Ethiopia. J Environ Occup Sci. 2013;2(1):9–14.CrossRef
31.
32.
Anagaw B, Shiferaw Y, Anagaw B, et al. Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia. BMC Res Notes. 2012;5:55.CrossRefPubMedPubMedCentral
33.
Ramos JM, Belda S, Reyes F, et al. Prevalence of HIV, HBV, HCV, HTLV and Treponema pallidum among patients attending a rural hospital in Southern Ethiopia. J Clin Virol. 2012;53(3):268–9.CrossRefPubMed
34.
Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;7:833.CrossRefPubMedPubMedCentral
35.
Moges F, Kebede Y, Kassu A, et al. Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia. EJHD. 2006;20:3.
36.
Tegegne D, Desta K, Tegbaru B, et al. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study. BMC Res Notes. 2014;7:239.CrossRefPubMedPubMedCentral
37.
Zenebe Y, Mulu W, Yimer M, et al. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118.CrossRefPubMedPubMedCentral
38.
Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of Hepatitis B Surface Antigen among Pregnant Women Attending Antenatal Care Service at Debre-Tabor Hospital, Northwest Ethiopia. Ethiopia J Health Sci. 2008;17(1):13–21.
39.
Tiruneh M. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiop Med J. 2008;46(4):359–66.PubMed
40.
Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. EJHD. 2005;19(1):45–50.
41.
Mekonnen D, Gebre-Selassie S, Fantaw S, et al. Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia. Pan Afr Med J. 2014;17:40.CrossRefPubMedPubMedCentral
42.
Shimelis T, Torben W, Medhin G, et al. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul’s General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect. 2008;84(1):37–41.CrossRefPubMed
43.
Bugssa G, Dessalegn B, Dimtsu B, Berhane Y. Prevalence and factors associated with HIV and hepatitis B virus infections among female commercial sex workers in Mekelle, Ethiopia: cross sectional study. IJPSR. 2015;6(1):135–46.
44.
Ayele AG, Gebre-Selassie S. Prevalence and Risk Factors of Hepatitis B and Hepatitis C Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa. Ethiopia: ISRN Tropical Medicine; 2012. 2013(ID 563821).
45.
Gebreselassie L. Spectrum of hepatitis B virus infection in Ethiopia. IARC Sci Publ. 1984;63:213–20.
46.
Tsega E, Nordenfelt E, Hansson BG, et al. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiop Med J. 1992;30(2 Suppl):1–33.PubMed
47.
Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol. 1991;34(4):232–6.CrossRefPubMed
48.
Tsega E, Hansson BG, Krawczynski K, et al. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis. 1992;14(4):961–5.CrossRefPubMed
49.
Tsega E, Nordenfelt E, Hansson BG. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg. 1995;89(2):171–4.CrossRefPubMed
50.
Tesfa H, Biadgo B, Getachew F, et al. Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital. BMC Res Notes. 2013;6:164.CrossRefPubMedPubMedCentral
51.
Taye S, Abdulkerim A, Hussen M. Prevalence of hepatitis B and C virus infections among patients with chronic hepatitis at Bereka Medical Center, Southeast Ethiopia: a retrospective study. BMC Res Notes. 2014;7:272.CrossRefPubMedPubMedCentral
52.
Tsega E, Tsega M, Mengesha B, et al. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol. 1988;17(4):874–9.CrossRefPubMed
53.
Manyazewal T, Sisay Z, Biadgilign S, et al. Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults. J Med Microbiol. 2014;63(5):742–7.PubMed
54.
Flatau E, Segol O, Shneour A, et al. Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991. Isr J Med Sci. 1992;29(6–7):387–9.
55.
Ayele W, Nokes DJ, Abebe A, et al. Higher prevalence of anti‐HCV antibodies among HIV‐positive compared to HIV‐negative inhabitants of Addis Ababa, Ethiopia. J Med Virol. 2002;68(1):12–7.CrossRefPubMed
56.
Frommel D, Tekle-Haimanot R, Berhe N, et al. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg. 1993;49(4):435–9.PubMed
57.
Gelaw B, Mengitsu Y. The prevalence of HBV, HCV and malaria parasites among blood donor in Amhara and Tigray regional states. EJHD. 2008;22(1):3–7.
58.
Ali S, Abera S, Mihret A, et al. Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-control Study. Interdiscip Perspect Infect Dis. 2012;2012:354656.
59.
Tsega E, Mengesha B, Hansson BG, et al. Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol. 1986;123(2):344–51.CrossRefPubMed
60.
Rapicetta M, Hailu K, Ponzetto A, et al. Delta hepatitis virus infection in Ethiopia. Eur J Epidemiol. 1988;4(2):185–8. 
61.
Tsega E, Krawczynski K, Hansson BG, et al. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J. 1993;31(3):173–81.
62.
Negero A, Sisay Z, Medhin G. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center. BMC Res Notes. 2011;4:35.
63.
Berhe H, Yismaw G, Addis Z. H/slassie H, Anagaw B, Unakal C. Seroprevalence and Associated Risk Factors of Human Immunodeficiency Virus and Hepatitis B Virus Infections among Prison Inmates. J Pharm Biomed Sci. 2013;30(23):1035–45.
64.
Wondimeneh Y, Alem M, Asfaw F, et al. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J. 2013;10:171.
65.
Belayneh F. Prevalence of Hepatitis B Virus Infection and Associated Factors among HIV Positive Adults Attending ART Clinic at Hawassa Referral Hospital, SNNPR, Ethiopia. OALib. 2015;02(05):1–7.
66.
Abreha T, Woldeamanuel Y, Pietsch C, et al. Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia. J Med Virol. 2011;83(5):776–82.
67.
Balew M, Moges F, Yismaw G, Unakal C. Assessment of hepatitis B virus and hepatitis C virus infections and associated risk factors in HIV infected patients at Debretabor hospital, South Gondar, Northwest Ethiopia. Asian Pac J Trop Dis. 2014;4(1):1–7.
68.
Taye S, Lakew M. Impact of hepatitis C virus co-infection on HIV patientsbefore and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia. BMC Immunol. 2013;14:23.
69.
Abera B, Zenebe Y, Mulu W, et al. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia. BMC Res Notes. 2014;7:838.
70.
Musa BM, Bussell S, Borodo MM, et al. Prevalence of hepatitis B virus infection in Nigeria, 2000–2013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18(2):163–72.
71.
Jayaraman S, Chalabi Z, Perel P, et al. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion. 2010;50(2):433–42.
72.
Mbanya DN, Takam D, Ndumbe PM. Serological findings amongst first-time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth? Transfus Med. 2003;13(5):267–73.
73.
74.
Chemtov D, Rosen H, Shtarkshall R, et al. A culturally specific educational program to reduce the risk of HIV and HBV transmission among Ethiopian immigrants to Israel: a preliminary report on training veteran immigrants as health educators. Isr J Med Sci. 1993;29(6–7):437–42.
75.
Richard MH. Cross-cultural Medicine and Diverse Health Beliefs Ethiopians Abroad. West J Med. 1997;166(1):29–36.
76.
Abeje G, Azage M. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2015;15:30.
77.
Bekele A, Tadesse A. Status of hepatitis B vaccination among surgeons practicing in Ethiopia: a cross sectional study. Ethiop Med J. 2014;52(3):107–12.
78.
Tsega E. Hepatocellular carcinoma in Ethiopia. A prospective clinical study of 100 patients. East Afr Med J. 1977;54(5):281–92.
79.
Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2(5):293–302.
80.
Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.
81.
Riou J, Aït Ahmed M, Blake A, et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat. 2016;23(4):244–55.
82.
Chaabna K, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C Virus Epidemiologyin Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis. PLoS One. 2016;11(2):e0149966.
83.
Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J. 2013;14:1.
84.
Tsega E, Nordenfelt E, Mengesha B, et al. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis. 1990;22(2):145–8.
85.
Gebreselassie L. Prevalence of specific markers of viral hepatitis A and B among an Ethiopian population. Bull World Health Organ. 1983;61(6):991–6.
86.
Stoszek SK, Engle RE, Abdel-Hamid M, et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg. 2006;100(2):89–94.
87.
Tsega E, Horton J, Nordenfelt E, et al. Do hospital personnel in hyperendemic areas require immunization against hepatitis B virus (HBV) infection? Is vertical transmission of HBV infection common in this group? Ethiop Med J. 1989;27(3):101–6.
88.
Enqueselassie F, Dejene A, Messele T, et al. Seroepidemiological study of Hepatitis B virus in Addis Ababa, Ethiopia. J Clin Epidemiol. 1997;50:S15.
89.
Tsega E, Mengesha B, Nordenfelt E, et al. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary? Trop Geogr Med. 1987;39(4):336–40.
90.
Zawde D, Sisay Y. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors. Ethiop Med J. 1991;29(4):175–83.
91.
Ben-Porath E, Hornstein L, Zeldis J, et al. Hepatitis B virus infection and liver disease in Ethiopian immigrants to Israel. Hepatology. 1986;6(4):662–6.
92.
Hornstein L, Ben-Porath E, Cuzin A, et al. Hepatitis B virus infection in Ethiopian immigrants to Israel. Isr J Med Sci. 1991;27(5):268–72.
93.
Chemtob D, Fassberg J, Kalka I, et al. Prevention strategy of hepatitis B virus infection among the Ethiopian community in Israel. Isr J Med Sci. 1991;27(5):273–7.
94.
Alkan ML, Maayan S, Belmaker I, et al. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia. Isr J Med Sci. 1993;29(6–7):390–2.
95.
Bisharat N, Elias M, Raz R, et al. Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel. Eur J Epidemiol. 1998;14(1):89–91.
96.
Zamir C, Dagan R, Zamir D, et al. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers. Pediatr Infect Dis J. 1999;18(3):262–6.
97.
Bezabeh YH, Muluneh DM, Gebere Sillassie S, Kloos H. Higher prevalence of Hepatitis B virus Infection among ARV- exposed than naive HIV-infected individuals in North Shewa Zone, Ethiopia. J HIV ADIS Res. 2015;71(1):10–7.
98.
Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015;12:204.
99.
Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at Bahir Dar Armed Forces General Hospital, Ethiopia. BMC Res Notes. 2015;8:737.
100.
Mulu W, Gidey B, Chernet A, et al. Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia. Ethiop J Health Sci. 2013;23(3):217–26.
Metadata
Title
Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
Authors
Yeshambel Belyhun
Melanie Maier
Andargachew Mulu
Ermias Diro
Uwe Gerd Liebert
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2090-1

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue

Research article

Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa

Erratum

Erratum to: Co-distribution and co-infection of chikungunya and dengue viruses

Research article

Clinical features of children hospitalized with influenza A and B infections during the 2012–2013 influenza season in Italy

Research article

Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study

Case report

Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis

Research article

Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits